Dr. Matthias Schiedel

Lehrstuhl für Pharmazeutische Chemie

Development and Initial Characterization of the First 18F-CXCR2-Targeting Radiotracer for PET Imaging of Neutrophils (2024) Spatz P, Chen X, Reichau K, Huber M, Mühlig S, Matsusaka Y, Schiedel M, et al. Journal article Development of a NanoBRET Assay Platform to Detect Intracellular Ligands for the Chemokine Receptors CCR6 and CXCR1 (2024) Huber M, Wurnig SL, Moumbock AF, Toy L, Kostenis E, Alonso Bartolomé A, Szpakowska M, et al. Journal article Fluorophore-Labeled Pyrrolones Targeting the Intracellular Allosteric Binding Site of the Chemokine Receptor CCR1 (2024) Toy L, Huber M, Lee M, Bartolomé AA, Ortiz Zacarías NV, Nasser S, Scholl S, et al. Journal article Development of a Fluorescent Ligand for the Intracellular Allosteric Binding Site of the Neurotensin Receptor 1 (2024) Vogt H, Shinkwin P, Huber M, Staffen N, Hübner H, Gmeiner P, Schiedel M, Weikert D Journal article New fluorogenic triacylglycerols as sensors for dynamic measurement of lipid oxidation (2024) Handke M, Beierlein F, Imhof P, Schiedel M, Hammann S Journal article Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin Deacetylation (2023) Sinatra L, Vogelmann A, Friedrich F, Tararina MA, Neuwirt E, Colcerasa A, König P, et al. Journal article Fluorescent Ligands Enable Target Engagement Studies for the Intracellular Allosteric Binding Site of the Chemokine Receptor CXCR2 (2023) Huber M, Wurnig S, Toy L, Weiler C, Merten N, Kostenis E, Hansen FK, Schiedel M Journal article Small Molecule Tools to Study Cellular Target Engagement for the Intracellular Allosteric Binding Site of GPCRs (2022) Huber M, Toy L, Schmidt M, Weikert D, Schiedel M Journal article Fluorescent Ligands Targeting the Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2 (2022) Toy L, Huber M, Schmidt M, Weikert D, Schiedel M Journal article Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration (2022) Vogelmann A, Schiedel M, Woessner N, Merz A, Herp D, Hammelmann S, Colcerasa A, et al. Journal article